Publications by authors named "Jami Fukui"

Claim this Profile
R
Randomized phase II comparison of single-agent carboplatin versus combination of carboplatin and everolimus for advanced triple negative breast cancer.
Rima Patel, Jami Fukui, Paula Klein, Erin Moshier, Hulya Kocyigit

Breast Cancer Res Treat· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reconsidering the definition of triple-negative breast cancer in the immune checkpoint inhibitor era: an optimal cut-off value for hormone receptor percentage of HER2-negative invasive breast cancer.
Takeo Fujii, Toshiaki Iwase, Yu Shen, Jami Fukui, Naoto T Ueno

Br J Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applicability of Oncotype DX Testing in a Diverse Breast Cancer Population in Hawaii.
Kyle Xia, Eileen Chen, Roxana Hu, Ian Pagano, Jami Fukui

Breast J· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Examining a Genomic Test in Predicting Extended Endocrine Benefit and Recurrence Risk in a Diverse Breast Cancer Population.
Ho Hyun Lee, Nicholas Siu-Li, Ian Pagano, Jami Aya Fukui

Curr Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the utility of ctDNA testing in high-risk breast cancer patients in a community setting: case series.
Kasen Wong, Alyssa Kameoka, Jami Aya Fukui

Ther Adv Med Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Behavioral-Emotional Functioning of Children of Parents with Early Compared to Advanced Cancer.
Frances Marcus Lewis, Pamela Ganschow, Deborah Manst, Heather Derry-Vick, Kenneth P Tercyak, Jami Fukui

J Palliat Med· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inflammatory breast cancer, best practice in the community setting.
Yoko Takahashi, Nithya Sridhar, Toshiaki Iwase, Ashley Marumoto, Jami Fukui

NPJ Breast Cancer· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of complementary and alternative medicine among cancer patients in Hawaii.
April Hamachi, Jobel Matriz, Jami Fukui

BMC Complement Med Ther· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differences in Breast Cancer Subtypes among Racial/Ethnic Groups.
Tamlyn Sasaki, Akash Liyanage, Surbhi Bansil, Anthony Silva, Ian Pagano, Jami Fukui

Cancers (Basel)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genomic Landscape of Circulating-Tumor DNA in a Diverse Cohort of Metastatic Breast Cancer Patients.
Shirley Cheng, Edward Tri Nguyen, Ian Pagano, Jami Aya Fukui

Oncol Res Treat· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial/Ethnic Differences Among Tumor-Infiltrating Lymphocytes in Breast Cancer Tumors.
Surbhi Bansil, Anthony Silva, Alana Taniguchi, Christina Wiedmer, Mayumi Fernandez, Jami Fukui

Oncologist· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial Disparities in Patient-Provider Communication During Telehealth Visits Versus Face-to-face Visits Among Asian and Native Hawaiian and Other Pacific Islander Patients With Cancer: Cross-sectional Analysis.
Jared D Acoba, Chelsea Yin, Michael Meno, Justin Abe, Ian Pagano, Jami Fukui

JMIR Cancer· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilizing Liquid Biopsy for Treatment Management in Bone-Dominant Metastatic Breast Cancer: A Case Report.
Shirley Cheng, Edward Tri Nguyen, Jami Aya Fukui

Case Rep Oncol· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Racial and Ethnic Disparities in Rates of Invasive Second Breast Cancer Among Women With Ductal Carcinoma In Situ in Hawai'i.
Kekoa Taparra, Jami Fukui, Jeffrey Killeen, Kenneth Sumida, Lenora W M Loo

JAMA Netw Open· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spotlight on Trastuzumab Deruxtecan (DS-8201,T-DXd) for Mutation Positive Non-Small Cell Lung Cancer.
Ibrahim Azar, Samer Alkassis, Jami Fukui, Fares Alsawah, Kalub Fedak

Lung Cancer (Auckl)· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Weight changes according to treatment in a diverse cohort of breast cancer patients.
Jami Fukui, Kami White, Timothy B Frankland, Caryn Oshiro, Lynne Wilkens

BMC Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recruiting Cancer Survivors to a Mobile Mindfulness Intervention in the United States: Exploring Online and Face-to-Face Recruitment Strategies.
Celine Isabelle Arnobit, Kiana Loo, Ian Pagano, Mai Uchiyama, Jami Fukui

Int J Environ Res Public Health· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Telehealth amid the COVID-19 pandemic: perception among Asian, Native Hawaiian and Pacific Islander cancer patients.
Michael Meno, Justin Abe, Jami Fukui, Christa Braun-Inglis, Ian Pagano

Future Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A cross-sectional study of breast pain in a diverse population of breast cancer patients.
Jami Fukui, Erin Bantum, Madison Meister, Shannon Lim, Ashley Davidson Marumoto

J Psychosoc Oncol Res Pract· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
If we build it they will come: targeting the immune response to breast cancer.
Margaret E Gatti-Mays, Justin M Balko, Sofia R Gameiro, Harry D Bear, Sangeetha Prabhakaran, Jami Fukui

NPJ Breast Cancer· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma.
Ajai Chari, Hearn J Cho, Amishi Dhadwal, Gillian Morgan, Lisa La, Jami Fukui

Blood Adv· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting Glutamatergic Signaling and the PI3 Kinase Pathway to Halt Melanoma Progression.
Stephen A Rosenberg, Scot A Niglio, Negar Salehomoum, Joseph L-K Chan, Byeong-Seon Jeong, Jami Fukui

Transl Oncol· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemical genetic screening for compounds that preferentially inhibit growth of methylthioadenosine phosphorylase (MTAP)-deficient Saccharomyces cerevisiae.
Yuwaraj Kadariya, Baiqing Tang, Cynthia B Myers, Jami Fukui, Jeffrey R Peterson

J Biomol Screen· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Isoform-selective chemical inhibition of mDia-mediated actin assembly.
Timothy J Gauvin, Jami Fukui, Jeffrey R Peterson, Henry N Higgs

Biochemistry· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An isoform-selective, small-molecule inhibitor targets the autoregulatory mechanism of p21-activated kinase.
Sean W Deacon, Alexander Beeser, Jami A Fukui, Ulrike E E Rennefahrt, Cynthia Myers

Chem Biol· April 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis